Manoel O C Rocha Selected Research

Chagas Disease (American Trypanosomiasis)

10/2019	MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease.
1/2017	Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.
1/2016	New serological tools for improved diagnosis of human tegumentary leishmaniasis.
11/2015	Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.
6/2015	Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease.
4/2013	Agreement among four drug information sources for the occurrence of warfarin drug interactions in Brazilian heart disease patients with a high prevalence of Trypanosoma cruzi infection.
2/2013	High interleukin 17 expression is correlated with better cardiac function in human Chagas disease.
4/2007	Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
8/2006	Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease.
9/2004	Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manoel O C Rocha Research Topics

Disease

12	Chagas Disease (American Trypanosomiasis) 10/2019 - 01/2004
7	Visceral Leishmaniasis (Kala Azar) 06/2022 - 01/2016
6	Leishmaniasis 06/2022 - 11/2015
5	Heart Diseases (Heart Disease) 09/2018 - 09/2004
4	Chagas Cardiomyopathy 01/2020 - 08/2007
4	Infections 01/2017 - 09/2004
4	Heart Failure 08/2006 - 01/2004
3	Inflammation (Inflammations) 01/2019 - 04/2004
3	Cardiomyopathies (Cardiomyopathy) 10/2004 - 01/2004
2	Ventricular Tachycardia 01/2020 - 09/2018
2	Fibrosis (Cirrhosis) 10/2019 - 10/2019
2	Leprosy (Hansen's Disease) 04/2018 - 01/2017
2	Hemorrhage 05/2013 - 04/2013
2	Left Ventricular Dysfunction 03/2009 - 10/2004
2	Ventricular Dysfunction 08/2006 - 04/2005
1	HIV Infections (HIV Infection) 11/2021
1	Coinfection 11/2021
1	Cutaneous Leishmaniasis 01/2019
1	Sudden Death 09/2018
1	Disease Progression 01/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2016
1	Parasitemia 06/2015
1	Drug-Related Side Effects and Adverse Reactions 05/2013
1	Hematuria 05/2013
1	Atrial Fibrillation 05/2013
1	Tuberculosis (Tuberculoses) 05/2013
1	Aneurysm (Aneurysms) 03/2009
1	Stroke (Strokes) 03/2009
1	Thrombosis (Thrombus) 03/2009
1	Transient Ischemic Attack 03/2009
1	Autonomic Nervous System Diseases (Dysautonomia) 08/2006
1	Cardiac Arrhythmias (Arrythmia) 04/2005

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 06/2022 - 04/2004
5	AntibodiesIBA 12/2019 - 08/2006
4	AntigensIBA 11/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2017
4	Interleukin-10 (Interleukin 10)IBA 04/2018 - 09/2004
4	CytokinesIBA 01/2017 - 09/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 04/2004
3	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2005 - 04/2004
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2022 - 03/2020
2	ChemokinesIBA 01/2019 - 01/2004
2	Amiodarone (Amiodarona)FDA LinkGeneric 09/2018 - 06/2015
2	Interleukin-17 (Interleukin 17)IBA 04/2018 - 02/2013
2	Warfarin (Coumadin)FDA LinkGeneric 05/2013 - 04/2013
1	EnzymesIBA 06/2022
1	ImmunosorbentsIBA 06/2022
1	Peptides (Polypeptides)IBA 11/2021
1	EpitopesIBA 11/2021
1	Recombinant ProteinsIBA 03/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2019
1	Meglumine AntimoniateIBA 01/2019
1	VaccinesIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	N 30IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2013
1	IceIBA 03/2009
1	Cholinergic Agents (Cholinergics)IBA 08/2006
1	AutoantibodiesIBA 08/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2004
1	Interleukin-12 (IL 12)IBA 09/2004
1	HLA-DR Antigens (HLA-DR)IBA 09/2004
1	Chemokine ReceptorsIBA 01/2004

Therapy/Procedure

5	Therapeutics 01/2020 - 08/2007
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 09/2018 - 04/2016
1	Artificial Respiration (Mechanical Ventilation) 01/2020
1	Aftercare (After-Treatment) 12/2019
1	Secondary Prevention 09/2018
1	Drug Therapy (Chemotherapy) 01/2018